699 results found

Language service providers (LSPs) specializing in the life sciences (SlatorPro) are aware of how complex and rigorous — not to mention costly — pharmaceutical translations can be.

On December 30, 2021, Chief ALJ Charles E. Bullock issued the public version (Part I, Part II, Part III, Part IV) of his October 28, 2021 initial determination ("ID") ...

On August 23, 2022, Director Vidal initiated a sua sponte Director review decision in two IPRs between Code200 and Bright Data (IPR2022-00861, -00862), which vacated the Board's denial...

In my first post about Pavo Solutions v. Kingston Technology a few weeks ago, I noted that the Federal Circuit rewrote claim language in the asserted patent by changing the claim element...

In Ex Parte Bandic, the PTAB ("the Board") has given an insight into how the Office intends to examine patent eligibility under the two-step Alice test ...

Baxalta Inc. and Baxalta GmbH (Baxalta) appealed a district court decision that the claims of U.S. Patent No. 7,033,590 were invalid for lack of enablement.

After determining that its competitor GKN's patent raised a potential risk of infringement for a product under development, JTEKT challenged the patentability of claims 1–7 of U.S. Patent No. 8,215,440 via inter partes review (IPR2016-00046).

Assignments are important and necessary because they protect the ownership interests in inventions and provide the right to prosecute patent applications and enforce patent rights.

The PTAB recently designated two decisions as precedential and one decision as informative with respect to 35 U.S.C. § 325(d). These cases discuss the Board's process for deciding when to use their discretion to deny institution.

We conclude that challenges under these circumstances should be incentivized at the appellate level and accordingly the remedy provided is appropriate.

Jadi Cell, LLC ("Jadi Cell") is the owner of US Patent No. 9,803,176, which is directed to stem cells with specific markers ("the Claimed Cells").

Over the past several months the PTAB has dramatically increased the number of discretionary denials of Petitions for Inter Partes Review (IPR). The extent of, and varying rationales for, the discretionary denials...

The U.S. Copyright Office has clarified its examination and registration practices for works that were produced with the assistance of artificial intelligence...

The Supreme Court found Ion Geophysical Corp. (Ion) responsible for profits WesternGeco LLC. lost as a result of Ion's supplying to foreign buyers the parts necessary to assemble the patented...

On December 20, 2021, ALJ Cameron Elliot issued the public version (Part I, Part II) of his final initial determination ("ID") of no violation of section 337 in Certain Digital Video-Capable Devices and Components Thereof (Inv. 337-TA-1224).

In 2013, the U.S. enacted the Biologics Price Competition and Innovation Act ("BPCIA"), 42 U.S.C. § 262 to allow for abbreviated biologics license applications ("aBLA") ...

In Pavo Solutions v. Kingston Technology (June 2022), the Federal Circuit rewrote claim language in the asserted patent by changing the claim element "for pivoting" from case to cover.